Skip Navigation



Journal of the National Cancer Institute Advance Access published online on October 9, 2007
JNCI Journal of the National Cancer Institute, doi:10.1093/jnci/djm215
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
99/20/1497-c    most recent
djm215v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Savage, L.
Right arrow Articles by Widener, A.
Related Collections
Right arrowRelated Article in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

MEMO TO THE MEDIA

PSA Velocity's Clinical Usefulness Remains Unclear

Liz Savage, Andrea Widener

jncimedia@oxfordjournals.org
301-841-1287

The first 10% of the full text of this article appears below.

Some studies have suggested that the rate of change of prostate-specific antigen (PSA) levels may correspond with prostate cancer survival. But this does not necessarily mean that PSA velocity will be valuable as a prostate cancer screening tool, according . . . [Full Text of this Article]

Contact:

Citation:

Note to Reporters:


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article in JNCI

Is Prostate-Specific Antigen Velocity Useful in Early Detection of Prostate Cancer? A Critical Appraisal of the Evidence
Ruth D. Etzioni, Donna P. Ankerst, Noel S. Weiss, Lurdes Y. T. Inoue, and Ian M. Thompson
J Natl Cancer Inst 2007 99: 1510-1515. [Abstract] [Full Text] [PDF]